Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
AMICUS THERAPEUTICS, INC.
| Metric | AMICUS THERAPEUTICS, INC. FOLDHealthcare |
|---|---|
| Quality Score | 65 / 100 |
| Revenue (latest) | $634M |
| Net income (latest) | −$27M |
| Operating margin | 5.2% |
| Net margin | −4.3% |
| Return on equity | −9.9% |
| Return on assets | −2.9% |
| Return on capital (ROCE) | 4.6% |
| Debt / equity | 2.46× |
| Revenue growth (YoY) | 20.0% |
| Altman Z″ (distress) | -5.81 |
| Accruals / assets | −6.3% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.